MX2015016603A - Composiciones de corticosteroides. - Google Patents
Composiciones de corticosteroides.Info
- Publication number
- MX2015016603A MX2015016603A MX2015016603A MX2015016603A MX2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A
- Authority
- MX
- Mexico
- Prior art keywords
- corticosteroid compositions
- compositions
- corticosteroid
- making
- methods
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361830531P | 2013-06-03 | 2013-06-03 | |
| PCT/US2014/040560 WO2014197398A1 (en) | 2013-06-03 | 2014-06-02 | Corticosteroid compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015016603A true MX2015016603A (es) | 2016-07-28 |
Family
ID=51014660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015016603A MX2015016603A (es) | 2013-06-03 | 2014-06-02 | Composiciones de corticosteroides. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3003272A1 (enExample) |
| JP (1) | JP2016520656A (enExample) |
| CN (1) | CN105263474A (enExample) |
| AR (1) | AR096459A1 (enExample) |
| AU (1) | AU2014275195A1 (enExample) |
| CA (1) | CA2912873A1 (enExample) |
| HK (1) | HK1223300A1 (enExample) |
| MX (1) | MX2015016603A (enExample) |
| WO (1) | WO2014197398A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011026076A2 (en) | 2009-08-31 | 2011-03-03 | Dr. Reddy's Laboratories Ltd. | Topical formulations comprising a steroid |
| US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
| ITUB20153460A1 (it) | 2015-09-08 | 2017-03-08 | Novamont Spa | Composizioni cosmetiche acquose contenenti esteri dell?acido pelargonico |
| MX391097B (es) * | 2017-11-27 | 2025-03-21 | Umecrine Cognition Ab | FORMULACIÓN FARMACÉUTICA DE 3A-ETINIL-3ß-HIDROXIANDROSTAN-17-ONA OXIMA. |
| WO2023277616A1 (ko) * | 2021-06-30 | 2023-01-05 | 주식회사 디네이쳐 | 중대가리풀 유래의 추출물을 포함하는 탈모기능성 조성물 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1048820A (en) * | 1963-05-29 | 1966-11-23 | Merck & Co Inc | Emollient compositions containing liquid fatty acid esters |
| US4305936A (en) * | 1980-10-09 | 1981-12-15 | Dermik Laboratories | Topical corticosteroid formulations |
| US4863738A (en) * | 1987-11-23 | 1989-09-05 | Alza Corporation | Skin permeation enhancer compositions using glycerol monooleate |
| US5087620A (en) * | 1990-05-17 | 1992-02-11 | Bristol-Myers Squibb Co. | Controlled dermal penetration enhancement using imidazoles |
| JP3471840B2 (ja) * | 1993-03-04 | 2003-12-02 | 日本ワイスレダリー株式会社 | 外用剤 |
| US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
| GB9618964D0 (en) * | 1996-09-11 | 1996-10-23 | Tillotts Pharma Ag | Oral composition |
| US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| PT1194109E (pt) * | 1999-06-25 | 2004-12-31 | Durham Pharmaceuticals Ltd | Formulacoes topicas compreendendo agentes de penetracao na pele e utilizacao dasmesmas |
| JP2001233772A (ja) * | 2000-02-23 | 2001-08-28 | Taiho Yakuhin Kogyo Kk | 外用剤組成物 |
| KR100433614B1 (ko) * | 2000-06-16 | 2004-05-31 | 주식회사 태평양 | 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제 |
| EP1648412B1 (en) * | 2003-07-07 | 2007-11-14 | Nares AB | Microemulsions and its use for preventing airway diseases |
| PL1744760T3 (pl) * | 2004-04-22 | 2015-04-30 | Acucort Ab | Kompozycja farmaceutyczna do ostrego leczenia glikokortykosteroidami |
| AU2005313601B2 (en) * | 2004-12-09 | 2012-05-24 | Bayer Intellectual Property Gmbh | Stabilisation of glucocorticoid esters with acids |
| US20060229364A1 (en) * | 2005-03-10 | 2006-10-12 | 3M Innovative Properties Company | Antiviral compositions and methods of use |
| FR2889662B1 (fr) * | 2005-08-11 | 2011-01-14 | Galderma Res & Dev | Emulsion de type huile-dans-eau pour application topique en dermatologie |
| FR2898498B1 (fr) * | 2006-03-15 | 2008-11-28 | Galderma Sa | Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant |
| GB2445539A (en) * | 2006-12-29 | 2008-07-16 | Ardana Bioscience Ltd | Bigel composition |
| US20090181068A1 (en) | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
| RS53809B1 (sr) * | 2010-06-11 | 2015-06-30 | Leo Pharma A/S | Farmaceutska kompozicija spreja za kožu koja sadrži analog vitamina d i kortikosteroid |
| WO2013076160A1 (en) * | 2011-11-21 | 2013-05-30 | Université Libre de Bruxelles | Sustained release formulations useful in the treatment of diseases |
| CN102940594A (zh) * | 2012-12-04 | 2013-02-27 | 艾能赛克机械设备(江苏)有限公司 | 一种头发调理剂 |
-
2014
- 2014-06-02 CN CN201480031734.4A patent/CN105263474A/zh active Pending
- 2014-06-02 JP JP2016518385A patent/JP2016520656A/ja active Pending
- 2014-06-02 HK HK16111676.0A patent/HK1223300A1/zh unknown
- 2014-06-02 MX MX2015016603A patent/MX2015016603A/es unknown
- 2014-06-02 AR ARP140102162A patent/AR096459A1/es unknown
- 2014-06-02 WO PCT/US2014/040560 patent/WO2014197398A1/en not_active Ceased
- 2014-06-02 AU AU2014275195A patent/AU2014275195A1/en not_active Abandoned
- 2014-06-02 EP EP14733041.9A patent/EP3003272A1/en not_active Withdrawn
- 2014-06-02 CA CA2912873A patent/CA2912873A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2912873A1 (en) | 2014-12-11 |
| AU2014275195A1 (en) | 2015-12-10 |
| CN105263474A (zh) | 2016-01-20 |
| WO2014197398A1 (en) | 2014-12-11 |
| EP3003272A1 (en) | 2016-04-13 |
| JP2016520656A (ja) | 2016-07-14 |
| AR096459A1 (es) | 2015-12-30 |
| HK1223300A1 (zh) | 2017-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
| AU2016202480A1 (en) | Seed-origin endophyte populations, compositions, and methods of use | |
| PH12016501763A1 (en) | Multispecific antibodies | |
| IL243752B (en) | Multispecific antibodies, preparations containing them and their uses | |
| AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
| MX2020005181A (es) | Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam). | |
| TN2017000246A1 (en) | Anti-c10orf54 antibodies and uses thereof | |
| EP3102670A4 (en) | Systems, methods, and compositions relating to combiomics | |
| MX2016003843A (es) | Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos. | |
| EP3082819A4 (en) | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith | |
| MX2021011906A (es) | Composiciones de liberacion retardada de linaclotida. | |
| MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
| MX2020004205A (es) | Composiciones antibioticas de ceftolozano. | |
| EP3068500A4 (en) | Fertilizer compositions and methods of making and using the same | |
| MX345926B (es) | Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas. | |
| AU2018253594A1 (en) | Dihydroxyphenyl neurotransmitter compounds, compositions and methods | |
| IN2013MU03641A (enExample) | ||
| PL2988764T3 (pl) | Kompozycje przeciwłupieżowe i sposoby ich zastosowania | |
| WO2014107596A8 (en) | Compositions and methods for polynucleotide transfection | |
| EP3071214A4 (en) | Salacia compositions, methods of treatment by their administration, and methods of their preparation | |
| MX2015016603A (es) | Composiciones de corticosteroides. | |
| WO2014146111A3 (en) | Analgesic compounds and methods of use | |
| EP3089745A4 (en) | Compounds, compositions, and methods for the treatment of cancers | |
| IN2014DN06617A (enExample) | ||
| EP3057972A4 (en) | Novel compositions, uses and methods for their preparation |